Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Jovanovic

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Molecular Genetics and Metabolism Reports|May 25, 2026
Effectiveness and tolerability of migalastat in adult Fabry disease: A single regional centre experienceEamon P McCarron, Rajkumar Chinnadurai, Karolina M Stepien, et al.
Molecular Genetics and Metabolism Reports|June 9, 2025
Real-world clinical outcomes in adult patients with Fabry disease: A 20-year retrospective observational cohort study from a single centreEamon P McCarron, Rajkumar Chinnadurai, Jonathan Meyer, et al.
Heart (British Cardiac Society)|August 28, 2023
Disease-specific therapy for the treatment of the cardiovascular manifestations of Fabry disease: a systematic reviewChristopher Orsborne, Nicholas Black, Josephine H Naish, et al.
Journal of Medical Genetics|September 2, 2025
Long-term efficacy of migalastat in females with Fabry diseaseStaci Kallish, Antonia Camporeale, Robert J Hopkin, et al.
Molecular Genetics and Metabolism|May 10, 2026
Natural history of hearing loss in adults with mucopolysaccharidoses across phenotype and genotypeEamon P McCarron, Karolina M Stepien, Neil Summerfield, et al.
Neurology|September 14, 2018
Enzyme replacement therapy and white matter hyperintensity progression in Fabry diseaseJames D Stefaniak, Laura M Parkes, Adrian R Parry-Jones, et al.
Journal of Nephrology|December 19, 2024
Epidemiology and early predictors of Fabry nephropathy: evaluation of long-term outcomes from a national Fabry centreFahmida Mannan, Rajkumar Chinnadurai, Ryan Wiltshire, et al.
Journal of Clinical Medicine|July 29, 2025
Clinical Efficacy and Real-World Effectiveness of Fabry Disease Treatments: A Systematic Literature ReviewAna Jovanovic, Eve Miller-Hodges, Felicia Castriota, et al.
Microbiology Resource Announcements|December 14, 2022
Draft Genome Sequence of Enterococcus dispar CoE-457-22, Isolated from Traditionally Produced Montenegrin Dry SausageBeatriz Daza Prieto, Nadja Raicevic, Johann Ladstätter, et al.
Orphanet Journal of Rare Diseases|July 21, 2023
Management of pain in Fabry disease in the UK clinical setting: consensus findings from an expert Delphi panelKarolina M Stepien, Alexander Broomfield, Duncan Cole, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Molecular Genetics and Metabolism Reports|May 25, 2026
Effectiveness and tolerability of migalastat in adult Fabry disease: A single regional centre experienceEamon P McCarron, Rajkumar Chinnadurai, Karolina M Stepien, et al.
Molecular Genetics and Metabolism Reports|June 9, 2025
Real-world clinical outcomes in adult patients with Fabry disease: A 20-year retrospective observational cohort study from a single centreEamon P McCarron, Rajkumar Chinnadurai, Jonathan Meyer, et al.
Heart (British Cardiac Society)|August 28, 2023
Disease-specific therapy for the treatment of the cardiovascular manifestations of Fabry disease: a systematic reviewChristopher Orsborne, Nicholas Black, Josephine H Naish, et al.
Journal of Medical Genetics|September 2, 2025
Long-term efficacy of migalastat in females with Fabry diseaseStaci Kallish, Antonia Camporeale, Robert J Hopkin, et al.
Molecular Genetics and Metabolism|May 10, 2026
Natural history of hearing loss in adults with mucopolysaccharidoses across phenotype and genotypeEamon P McCarron, Karolina M Stepien, Neil Summerfield, et al.
Neurology|September 14, 2018
Enzyme replacement therapy and white matter hyperintensity progression in Fabry diseaseJames D Stefaniak, Laura M Parkes, Adrian R Parry-Jones, et al.
Journal of Nephrology|December 19, 2024
Epidemiology and early predictors of Fabry nephropathy: evaluation of long-term outcomes from a national Fabry centreFahmida Mannan, Rajkumar Chinnadurai, Ryan Wiltshire, et al.
Journal of Clinical Medicine|July 29, 2025
Clinical Efficacy and Real-World Effectiveness of Fabry Disease Treatments: A Systematic Literature ReviewAna Jovanovic, Eve Miller-Hodges, Felicia Castriota, et al.
Microbiology Resource Announcements|December 14, 2022
Draft Genome Sequence of Enterococcus dispar CoE-457-22, Isolated from Traditionally Produced Montenegrin Dry SausageBeatriz Daza Prieto, Nadja Raicevic, Johann Ladstätter, et al.
Orphanet Journal of Rare Diseases|July 21, 2023
Management of pain in Fabry disease in the UK clinical setting: consensus findings from an expert Delphi panelKarolina M Stepien, Alexander Broomfield, Duncan Cole, et al.
Pageof 6